Enhanced skin permeation of 6-methoxy-2-naphthylacetic acid by salt formation

被引:2
作者
Pawar, Vijay [1 ]
Kumar, H. Yogish [2 ]
Giridhar, Rajani [1 ]
Yadav, Mange Ram [1 ]
机构
[1] Maharaja Sayajirao Univ Baroda, Fac Engn & Technol, Dept Pharm, Vadodara 390001, India
[2] Delhi Inst Pharmaceut Sci & Res DIPSAR, New Delhi, India
关键词
6-MNA; lipophilicity; NSAID; salts; skin permeation; solubility; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PERMEABILITY; NSAIDS;
D O I
10.3109/10717544.2014.894595
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of this work was to prepare salts of 6-methoxy-2-naphthylacetic acid (6-MNA) to improve its physicochemical properties for percutaneous application. 6-MNA, an active metabolite of non-steroidal anti-inflammatory drug nabumetone has long half life and has the tendency to penetrate well into synovial fluid. The physicochemical properties of 6-MNA salts were investigated by solubility measurements, differential scanning calorimetry (DSC) and infrared (IR). The DSC thermograms and Fourier transform infrared (FT-IR) spectra indicated that 6-MNA formed salts with organic and alkali metal bases. Among the series, salts formed with amine bases (ethanolamine, diethanolamine, triethanolamine and diethylamine) had lower melting points while alkali metal salt (sodium) had higher melting point than 6-MNA. The salts had higher solubilities than 6-MNA as determined in phosphate buffer at pH 5.0 and 7.4. There is no significant difference in partition coefficient (log P) values between salts and 6-MNA at pH 5.0 but, at pH 7.4, the log P values for the salts increased by 4-10 times as compared to 6-MNA. In vitro permeation studies showed that all the salts increased the flux in comparision to 6-MNA, and the ethanolamine salt (1b) was found to be having 7.7 and 9.4 times higher permeability as compared to 6-MNA at pH 5.0 and 7.4, respectively.
引用
收藏
页码:359 / 366
页数:8
相关论文
共 22 条
  • [1] New guidelines for topical NSAIDs in the osteoarthritis treatment paradigm
    Altman, Roy D.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (12) : 2871 - 2876
  • [2] ARSENIJEVIC L, 1988, ORG SYNTH, V50-9, P34
  • [3] Enhanced percutaneous absoption of piroxicam via salt formation with ethanolamines
    Cheong, HA
    Choi, HK
    [J]. PHARMACEUTICAL RESEARCH, 2002, 19 (09) : 1375 - 1380
  • [4] Clinical pharmacokinetics of nabumetone - The dawn of selective cyclo-oxygenase-2 inhibition?
    Davies, NM
    [J]. CLINICAL PHARMACOKINETICS, 1997, 33 (06) : 403 - 416
  • [5] TOPICAL NONSTEROIDAL ANTIINFLAMMATORY DRUGS AND ADMISSION TO HOSPITAL FOR UPPER GASTROINTESTINAL-BLEEDING AND PERFORATION - A RECORD LINKAGE CASE-CONTROL STUDY
    EVANS, JMM
    MCMAHON, AD
    MCGILCHRIST, MM
    WHITE, G
    MURRAY, FE
    MCDEVITT, DG
    MACDONALD, TM
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1995, 311 (6996): : 22 - 26
  • [6] EVANS JMM, 1995, QJM-MON J ASSOC PHYS, V88, P551
  • [7] The use of complexation with alkanolamines to facilitate skin permeation of mefenamic acid
    Fang, LA
    Numajiri, S
    Kobayashi, D
    Morimoto, Y
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 262 (1-2) : 13 - 22
  • [8] NABUMETONE - A REAPPRAISAL OF ITS PHARMACOLOGY AND THERAPEUTIC USE IN RHEUMATIC DISEASES
    FRIEDEL, HA
    LANGTRY, HD
    BUCKLEY, MM
    [J]. DRUGS, 1993, 45 (01) : 131 - 156
  • [9] Furniss BS, 1996, VOGELS TXB PRACTICAL, P987
  • [10] Gerard C, 1991, J CONTROL RELEASE, V16, P77